Overview

Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of sugammadex in reversing profound neuromuscular block induced by rocuronium in infant patients
Phase:
Phase 4
Details
Lead Sponsor:
Baskent University
Treatments:
Rocuronium
Sevoflurane